Spineway S.A (ALSPW) | Stock Overview & Key Data
Spineway S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €0.22 on October 15, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Spineway S.A
ALSPW
|
5.76M Small-cap | -7.69% | -14.29% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% |
| 88.12B Large-cap | 6.30% | 6.23% | -6.90% | -6.90% | -6.90% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | |
|
Sartorius Stedim
DIM
|
15.79B Large-cap | -2.23% | 12.51% | 3.06% | 3.06% | 3.06% | 6.42% | 6.42% | 6.42% | 6.42% | 6.42% | 6.42% |
|
Crossject S.A
ALCJ
|
105.59M Small-cap | 1.05% | 1.05% | -3.98% | -7.21% | -9.81% | 6.04% | -50.89% | -39.31% | -72.74% | -83.28% | -83.28% |
|
Visiomed Group SA
ALVMG
|
52.83M Small-cap | 5.56% | -5.00% | 5.56% | 5.56% | 5.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
Bonyf N.V
MLBON
|
2.48M Small-cap | 0.00% | -0.47% | -6.25% | -67.44% | -14.29% | -69.78% | -65.00% | -66.40% | -66.40% | -66.40% | -66.40% |
Ownership & Short Interest
Calculate Your Spineway S.A Investment Returns
Long-Term Investment Performance Analysis
Spineway S.A stock price in Mar 2026 was €0.16, A €1,000.00 lump sum investment in Spineway S.A made 0 years ago would be worth approximately €750.00 today, representing a negative return of -25.00%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALSPW's 52-week high and low?
- In the last 52 weeks, Spineway S.A reached a high of €0.26 (on October 14, 2025) and a low of €0.10 (on July 23, 2025).
- What is the market cap and P/E ratio for ALSPW?
- Curious about Spineway S.A's size and valuation? Its market capitalization stands at 5.76M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.20, and the forward P/E (looking ahead) is -2.31.
- Does ALSPW pay dividends? If so, what's the yield?
- As for dividends, Spineway S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Spineway S.A's main competitors or similar companies to consider before investing?
When looking at Spineway S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL88.12B Healthcare Medical Instruments & Supplies -6.21% -6.21% Sartorius Stedim
DIM15.79B Healthcare Medical Instruments & Supplies 6.42% 6.42% Crossject S.A
ALCJ105.59M Healthcare Medical Instruments & Supplies 6.04% -50.89% Visiomed Group SA
ALVMG52.83M Healthcare Medical Instruments & Supplies 0.00% 0.00% Bonyf N.V
MLBON2.48M Healthcare Medical Instruments & Supplies -69.78% -65.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Spineway S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Spineway S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -9.46%, the Debt to Equity ratio from the most recent quarter is 6.63, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSPW?
- Looking at Spineway S.A's growth, its revenue over the trailing twelve months (TTM) was €13M. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSPW stock is held by insiders and institutions?
- Wondering who owns Spineway S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.